(QQXT) First Trust NASDAQ-100 - Ratings and Ratios
Consumer, Healthcare, Industrial, Communication, Retail
Dividends
| Dividend Yield | 1.20% |
| Yield on Cost 5y | 1.60% |
| Yield CAGR 5y | 42.41% |
| Payout Consistency | 87.9% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 10.3% |
| Value at Risk 5%th | 17.4% |
| Relative Tail Risk | 2.46% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.30 |
| Alpha | -6.42 |
| CAGR/Max DD | 0.76 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.422 |
| Beta | 0.727 |
| Beta Downside | 0.747 |
| Drawdowns 3y | |
|---|---|
| Max DD | 14.92% |
| Mean DD | 2.86% |
| Median DD | 2.33% |
Description: QQXT First Trust NASDAQ-100 November 17, 2025
The First Trust NASDAQ-100 Ex-Technology Sector Index Fund (QQXT) is an U.S.-based ETF that must allocate at least 90 % of its net assets (including any borrowing) to the securities that make up its benchmark. The benchmark is an equal-weighted version of the NASDAQ-100, stripped of any constituents classified as “technology” under the ICB taxonomy, thereby giving a flat exposure to the remaining large-cap non-tech firms.
Key quantitative points (as of the most recent public filing) include an expense ratio of 0.60 %, total assets under management of roughly $1.2 billion, and a 30-day turnover of about 12 %, reflecting the index’s quarterly rebalancing schedule. Sector weightings are dominated by Consumer Discretionary (~30 %), Health Care (~20 %) and Industrials (~15 %). Because the fund is equal-weighted, each holding caps at roughly 1 % of assets, which reduces concentration risk relative to market-cap-weighted peers. Macro-level drivers such as U.S. consumer spending trends, Fed policy on interest rates, and corporate earnings growth in non-tech sectors are the primary levers for performance.
If you want a data-driven, side-by-side comparison of QQXT’s risk-adjusted metrics and valuation multiples versus alternative large-blend ETFs, the analytics platform ValueRay offers a useful, no-friction tool for deeper research.
What is the price of QQXT shares?
Over the past week, the price has changed by +0.41%, over one month by +2.78%, over three months by +2.41% and over the past year by +7.74%.
Is QQXT a buy, sell or hold?
What are the forecasts/targets for the QQXT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 109.6 | 9.7% |
QQXT Fundamental Data Overview December 17, 2025
Beta = 0.9
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 233.6m USD (233.6m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 233.6m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 233.6m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.69% (E(233.6m)/V(233.6m) * Re(8.69%) + (debt-free company))
Discount Rate = 8.69% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for QQXT ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle